UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053516
Receipt number R000061077
Scientific Title Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient
Date of disclosure of the study information 2024/02/01
Last modified on 2024/02/01 17:54:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient

Acronym

Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient

Scientific Title

Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient

Scientific Title:Acronym

Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient

Region

Japan


Condition

Condition

onychomycosis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In the present study, we continued the follow-up and investigated the efficacy of re-administration of fosravuconazole in patients with recurrent onychomycosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)Patient characteristics: Sex, age, and presence or absence of diabetes/renal failure (on dialysis treatment)/use of immunosuppressive drugs.

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Among patients aged 65 years or older who visited our dermatology outpatient clinic from November 2018 to March 2021, those who were diagnosed with onychomycosis by KOH-based direct microscopy and requested oral treatment were included in the study. Fosravuconazole was administered orally (100 mg/day) for an initial 12 weeks. One hundred and twenty-five patients judged to have responded to the treatment at 48 weeks after completion of the treatment were followed up for subsequent 144 weeks. Patients who experienced a recurrence at less than 24 weeks during the follow-up period were assigned to the short-term recurrence group, and those who experienced a recurrence at 24 weeks or later were assigned to the long-term recurrence group. Fosravuconazole was re-administered and the efficacy was evaluated in each group.

Key exclusion criteria

Patients with hepatic impairment (AST or ALT: 2.5 times the upper reference limit or 100 U/L) and patients having been treated with warfarin were excluded from this study.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name AYAKA
Middle name
Last name OKUBO

Organization

Muroran City General Hospital

Division name

Department of Dermatology

Zip code

051-8512

Address

3-8-1 Yamate-cho, Muroran-shi, Hokkaido 051-8512, Japan.

TEL

09050762413

Email

m59_anomura@yahoo.co.jp


Public contact

Name of contact person

1st name AYAKA
Middle name
Last name OKUBO

Organization

Muroran City General Hospital

Division name

Department of Dermatology

Zip code

0510012

Address

3-8-1 Yamate-cho, Muroran-shi, Hokkaido 051-8512, Japan.

TEL

09050762413

Homepage URL


Email

murohosp191@kujiran.jp


Sponsor or person

Institute

Muroran City General Hospital

Institute

Department

Personal name



Funding Source

Organization

Muroran City General Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Muroran City General Hospital

Address

3-8-1 Yamate-cho, Muroran-shi, Hokkaido 051-8512, Japan.

Tel

0143253111

Email

murohosp191@kujiran.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results

The results suggest that the re-administration of fosravuconazole is safe and as effective as the first administration for elderly patients with recurrent onychomycosis.

Results date posted

2024 Year 02 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2024 Year 03 Month 01 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 09 Month 01 Day

Date of IRB

2018 Year 09 Month 01 Day

Anticipated trial start date

2018 Year 09 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Other related information


Management information

Registered date

2024 Year 02 Month 01 Day

Last modified on

2024 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061077


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name